@joanmontero.bsky.social
Associate Professor at University of Barcelona (Campus Clínic). Leading the Cell death, senescence and cancer precision medicine group. ICREA Acadèmia awardee. Former IBEC/DFCI/HMS. Board member of the SfPM. www.themonterolab.com
Congratulations @senescel.org for this great meeting! Total success! Dr. Clara Alcon presented our work focused on TIS-mediated resistance, and how to detect it using BH3 profiling and overcome it targeting anti-apoptotic proteins. Can’t wait for the next meeting!
08.11.2025 08:50 — 👍 3 🔁 1 💬 0 📌 1🚨Excited to announce the seminar by Kushtrim Kryeziu, PhD (Oslo University) on "Functional Precision Oncology for Metastatic Colorectal Cancer". Join us TODAY, at 12 PM EDT, open to everyone! Don't miss it and consider joining the SFPM
www.sfpm.io/seminars
#RecercaUB | 🧠 Un nou estudi aconsegueix revertir els efectes de l’Alzheimer en ratolins amb l’ús de nanopartícules portadores de molècules terapèutiques.
🔬 Hi han participat Lorena Ruiz Pérez, de #FísicaUB, i Giuseppe Battaglia, tots dos membres @ibecbarcelona.eu.
Congratulations Tony! I wish you every success in this new endeavor and I have no doubt that your vision, leadership and integrity will bring great value to the NCI. I'm deeply grateful for your invaluable mentorship, friendship and encouragement over the years. Amazing news!
30.09.2025 06:09 — 👍 2 🔁 0 💬 0 📌 0
A must watch video: How functional precision medicine could be the future of cancer care. Truly inspiring TED talk by Dr. Diana Azzam
www.youtube.com/watch?v=CqLC...
Moltes felicitats Quim i equip!
22.07.2025 08:38 — 👍 1 🔁 0 💬 0 📌 0Parece un déja-vu con respecto a la DANA si no fuese porque que en Texas no había nadie para avisar y en Valencia si. Pero ambas desgraciad tienen en común que la incompetencia cuesta vidas
11.07.2025 13:22 — 👍 4 🔁 0 💬 0 📌 0
Delighted to see good research highlighted on TV @som.3cat.cat
Congratulations @tceliaterrassa.bsky.social and team! Hope your findings help to better treat metastatic breast cancer patients.
www.3cat.cat/324/cancer-d...
Osti, perquè em dius que es gazpacho però podria ben bé ser crema de pèsols
10.07.2025 20:44 — 👍 1 🔁 0 💬 1 📌 0This is going to be a really cool meeting with great invited speakers, but also offering the possibility to showcase your work independently of your career stage.
It will also be loads of fun in Barcelona, with the most friendly and welcoming community ☺️
Rush to register at senescel2025.senescel.org
✨ Excited to announce a talk by Rita Fior, PhD on "Zebrafish Avatars for Personalized Medicine & Discovery of Innate Immune Mechanisms"! Join us next Wednesday, July 9, 2025, at 12 PM EDT, organized by @thesfpm.bsky.social. Don't miss it!
www.sfpm.io/seminars
🚨 New Article Alert! Dive into a fantastic review by several @thesfpm.bsky.social members on how new technologies and functional approaches are revolutionizing personalized cancer treatment. Don't miss out on this game-changing insight!
www.nature.com/articles/s41...
Congratulations Sandra and team! Fantastic work!
28.04.2025 21:52 — 👍 0 🔁 0 💬 0 📌 0
Online now concurrent with the #AACR25 oral presentation by Cancer Discovery Early Career Award Winner @Sandra_Misale: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations doi.org/10.1158/2159...
Quote of the day: “If you think research is expensive, try disease.” Mary Lasker
15.04.2025 10:15 — 👍 2 🔁 1 💬 0 📌 0
Excited to share our latest findings! 🫁 Dynamic BH3 profiling predicts ALK-TKI response in NSCLC, revealing new therapeutic combos to overcome resistance. Read the summary here:
web.ub.edu/en/web/actua...
Excited to share our latest findings! 🫁 Dynamic BH3 profiling predicts ALK-TKI response in NSCLC, revealing new therapeutic combos to overcome resistance. Congratulations to Dr. Martín and to all our collaborators
@ub.edu @ibecbarcelona.eu @hospitalclinic.bsky.social CIBERBBN
rdcu.be/eennu
Do not miss this great talk tomorrow at 5pm CET (12pm EDT): Zinaida Perova (EMBL) "Leveraging CancerModels.Org: Enhancing Precision Oncology Through Collaborative Cancer Model Resources". @thesfpm.bsky.social
www.sfpm.io/seminars
Happy International Women’s day to all the brave, intelligent, loving, amazing women worldwide!
08.03.2025 16:36 — 👍 1 🔁 0 💬 0 📌 0🚀 Exciting news! Our new research lab website is live! 🌐 Explore cutting-edge projects, publications, and more. Visit us at themonterolab.com
13.02.2025 10:40 — 👍 0 🔁 0 💬 0 📌 0
Papers on cell death from January 2025
Caspases, pyroptosis, apoptosis, cytotoxicity, ferroptosis, necroptosis, Bcl-2 family and more!
ApoList
celldeath.wordpress.com/2025/02/04/a...
On #WorldCancerDay #WCD2025 and every day, our lab is committed to finding a cure for cancer through groundbreaking research and advanced functional precision medicine. Together, we can find a treatment for each patient and beat cancer @ub.edu @thesfpm.bsky.social
04.02.2025 10:30 — 👍 2 🔁 1 💬 0 📌 0
An exciting multicenter phase 2 functional precision medicine clinical trial showing how a rapid ex vivo venetoclax sensitivity assay was the strongest predictor for a favorable treatment response and survival in relapsed/refractory secondary AML
ashpublications.org/blood/articl...
Moltes felicitats a tot l’equip!
22.01.2025 14:02 — 👍 1 🔁 0 💬 0 📌 0
#RecercaUB | 🔬 Un estudi liderat per la #UniBarcelona descriu un mecanisme per eliminar les cèl·lules perjudicials originades per tractaments oncològics
📷 Dirigeix el treball Joan Montero. La primera autora és Clara Alcon, tots dos de @medicinacs-ub.bsky.social.
👉 web.ub.edu/web/actualit...
Thrilled to receive the prestigious ICREA Acadèmia award! A heartfelt thank you to everyone at @ub.edu & ICREA - Institució Catalana de Recerca i Estudis Avançats who made this possible.
14.01.2025 14:40 — 👍 1 🔁 0 💬 0 📌 0We show how melanoma senescent cells become dependent on BCL-xL by downregulating HRK and increasing BCL-xL:BAK binding. This explains why navitoclax is a good senolytic. @ub.edu CampusClinicUB
CIBERBBN @ibecbarcelona.eu Great work by Dr. Clara Alcon!
Proud to share three papers from our lab rdcu.be/d2hUm @ub.edu , Letai lab rdcu.be/d5rb3, and R. Bernards rdcu.be/d5rjW all showing predictable mitochondrial control of senescent cell death, using BH3 profiling as a biomarker for senolytic therapy.
07.01.2025 15:25 — 👍 5 🔁 1 💬 1 📌 0Buon Natale Ivano!
25.12.2024 13:20 — 👍 1 🔁 0 💬 0 📌 0Merry Christmas!
24.12.2024 18:18 — 👍 2 🔁 0 💬 1 📌 0
